Valuation : EirGenix Inc.

Market Cap 15.2B 480M 412M 386M 353M 665M 45.83B 667M 4.57B 1.79B 23.1B 1.8B 1.76B 76.45B P/E 2026 *
-33x
P/E 2027 * 88.1x
Enterprise Value 13.96B 441M 378M 354M 324M 611M 42.07B 612M 4.19B 1.64B 21.2B 1.65B 1.62B 70.18B EV / Sales 2026 *
9.47x
EV / Sales 2027 * 6.13x
Free-Float
59.94%
Yield 2026 *
-
Yield 2027 * -
1 day-1.19%
1 week+2.05%
Current month+10.81%
1 month+8.99%
3 months+18.47%
6 months-18.52%
Current year-19.45%
1 week 49.3
Extreme 49.3
53
1 month 44.3
Extreme 44.3
53
Current year 40.15
Extreme 40.15
67.6
1 year 40.15
Extreme 40.15
84.3
3 years 40.15
Extreme 40.15
111
5 years 40.15
Extreme 40.15
163.5
10 years 21.55
Extreme 21.55
195
Manager TitleAgeSince
Chief Executive Officer - 2013-03-31
Director of Finance/CFO - 2016-05-02
Corporate Officer/Principal - 2019-05-19
Director TitleAgeSince
Director/Board Member - 2013-06-13
Director/Board Member - 2016-09-12
Chairman - 2022-06-09
Change 5-day change 1-year change 3-year change Capi.($)
-1.19%+2.05%-19.19%-46.67% 480M
-0.87%-2.29%+37.61%-2.73% 81.36B
-4.60%+7.09%+468.80%+27.55% 59.75B
-1.14%+3.28%-20.09%-35.83% 59.19B
+0.76%+3.53%+0.08%+36.18% 53.33B
+0.41%+1.84%+10.29%+171.67% 49.09B
+0.19%+3.34%+62.44%-16.23% 32.66B
-0.30%+0.41%+50.57%+100.03% 25.97B
+0.28%+5.18%+18.81%+209.93% 24.39B
+0.78%+0.47%+61.53%+123.40% 16.91B
Average -0.17%+2.42%+67.09%+56.73% 40.31B
Weighted average by Cap. -0.23%+2.40%+87.40%+46.91%

Financials

2026 *2027 *
Net sales 1.47B 46.52M 39.93M 37.39M 34.23M 64.49M 4.44B 64.67M 443M 173M 2.24B 175M 171M 7.41B 2.34B 73.95M 63.48M 59.43M 54.42M 103M 7.06B 103M 704M 275M 3.56B 278M 272M 11.78B
Net income -458M -14.45M -12.41M -11.62M -10.64M -20.04M -1.38B -20.1M -138M -53.77M -696M -54.27M -53.1M -2.3B 172M 5.43M 4.66M 4.36M 3.99M 7.53M 518M 7.55M 51.66M 20.19M 261M 20.38M 19.94M 865M
Net Debt -1.25B -39.36M -33.78M -31.63M -28.96M -54.56M -3.76B -54.71M -375M -146M -1.89B -148M -145M -6.27B -838M -26.45M -22.7M -21.25M -19.46M -36.66M -2.53B -36.77M -252M -98.39M -1.27B -99.3M -97.15M -4.21B
Logo EirGenix Inc.
EirGenix Inc is a Taiwan-based company primarily engaged in the development of antibody drugs and the manufacture of biopharmaceuticals. Its main businesses include the provision of Contract Development & Manufacturing Organization (CDMO) services, the construction of cell strain, the manufacture of clinical trial medicine, analytical science and protein identification, and PIC/S manufacturing plant to provide clinical trial drug production.
Employees
1,000
Date Price Change Volume
26-08-27 NT$50.20 -0.59% 364,960
26-08-26 NT$50.50 +1.61% 450,509
26-08-25 NT$49.70 -1.19% 432,331
26-08-24 NT$50.30 -1.76% 514,086
26-08-21 NT$51.20 -0.78% 728,147
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
50.20TWD
Average target price
111.00TWD
Spread / Average Target
+121.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6589 Stock